Blood Vessel Maturation by Disintegrin in Oxygen-Induced Retinopathy

References

• Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 2007;14:179–183
   PubMed Web of Science ®Google Scholar
• Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Meta-analysis for Eye Disease Study G. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35:556–564
   PubMed Web of Science ®Google Scholar
• Chistiakov DA. Diabetic retinopathy: pathogenic mechanisms and current treatments. Diabetes Metab Syndr 2011;5:165–172
   PubMedGoogle Scholar
• Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med 2012;366:1227–1239
   PubMed Web of Science ®Google Scholar
• Heng LZ, Comyn O, Peto T, Tadros C, Ng E, Sivaprasad S, et al. Diabetic retinopathy: pathogenesis, clinical grading, management and future developments. Diabet Med 2013;30:640–650
   PubMed Web of Science ®Google Scholar
• Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res 2005;97:512–523
   PubMed Web of Science ®Google Scholar
• Bergers G, Song S. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 2005;7:452–464
   PubMed Web of Science ®Google Scholar
• Gerhardt H, Betsholtz C. Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 2003;314:15–23
   PubMed Web of Science ®Google Scholar
• Hammes HP, Lin J, Wagner P, Feng Y, Vom Hagen F, Krzizok T, et al. Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy. Diabetes 2004;53:1104–1110
   PubMed Web of Science ®Google Scholar
• Koh GY. Orchestral actions of angiopoietin-1 in vascular regeneration. Trends Mol Med 2013;19:31–39
   PubMed Web of Science ®Google Scholar
• Fuxe J, Tabruyn S, Colton K, Zaid H, Adams A, Baluk P, et al. Pericyte requirement for anti-leak action of angiopoietin-1 and vascular remodeling in sustained inflammation. Am J Pathol 2011;178:2897–2909
   PubMed Web of Science ®Google Scholar
• Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996;87:1171–1180
   PubMed Web of Science ®Google Scholar
• Cai J, Kehoe O, Smith GM, Hykin P, Boulton ME. The angiopoietin/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy. Invest Ophthal Vis Sci 2008;49:2163–2171
   PubMed Web of Science ®Google Scholar
• Hynes RO. Cell-matrix adhesion in vascular development. J Thromb Haemost 2007;5:32–40
   PubMed Web of Science ®Google Scholar
• Kim C, Ye F, Ginsberg MH. Regulation of integrin activation. Ann Rev Cell Dev Biol 2011;27:321–345
   PubMed Web of Science ®Google Scholar
• Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, et al. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994;9:1157–1164
   Web of Science ®Google Scholar
• Hong SY, Koh YS, Chung KH, Kim DS. Snake venom disintegrin, saxatilin, inhibits platelet aggregation, human umbilical vein endothelial cell proliferation, and smooth muscle cell migration. Thromb Res 2002;105:79–86
   PubMed Web of Science ®Google Scholar
• Jeon OH, Kim D, Choi YJ, Kim SH, Choi WS, Kim DS. Novel function of human ADAM15 disintegrin-like domain and its derivatives in platelet aggregation. Thromb Res 2007;119:609–619
   PubMed Web of Science ®Google Scholar
• Tucker GC. Integrins: molecular targets in cancer therapy. Curr Oncol Rep 2006;8:96–103
   PubMedGoogle Scholar
• Stupp R, Ruegg C. Integrin inhibitors reaching the clinic. J Clin Oncol 2007;25:1637–1638
   PubMed Web of Science ®Google Scholar
• Reynolds AR, Hart IR, Watson AR, Welt JC, Silva RG, Robinson SD, et al. Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors. Nat Med 2009;15:392–400
   PubMed Web of Science ®Google Scholar
• Armstrong PC, Peter K. GPIIb/IIIa inhibitors: from bench to bedside and back to bench again. Thromb Haemost 2012;107:808–814
   PubMed Web of Science ®Google Scholar
• van Wijngaarden P, Coster DJ, Brereton HM, Gibbins IL, Williams KA. Strain-dependent differences in oxygen-induced retinopathy in the inbred rat. Invest Ophthal Vis Sci 2005;46:1445–1452
   PubMed Web of Science ®Google Scholar
• Newman H, Shapira S, Spierer O, Kraus S, Rosner M, Pri-Chen S, et al. Involvement of CD24 in angiogenesis in a mouse model of oxygen-induced retinopathy. Curr Eye Res 2012;37:532–539
   PubMed Web of Science ®Google Scholar
• Nandgaonkar BN, Rotschild T, Yu K, Higgins RD. Indomethacin improves oxygen-induced retinopathy in the mouse. Pediatr Res 1999;46:184–188
   PubMed Web of Science ®Google Scholar
• Kenyon BM, Voest EE, Chen CC, Flynn E, Folkman J, D'Amato RJ. A model of angiogenesis in the mouse cornea. Invest Ophthal Vis Sci 1996;37:1625–1632
   PubMed Web of Science ®Google Scholar
• Becker CM, Rohwer N, Funakoshi T, Cramer T, Bernhardt W, Birsner A, et al. 2-methoxyestradiol inhibits hypoxia-inducible factor-1{alpha} and suppresses growth of lesions in a mouse model of endometriosis. Am J Pathol 2008;172:534–544
   PubMed Web of Science ®Google Scholar
• von Tell D, Armulik A, Betsholtz C. Pericytes and vascular stability. Exp Cell Res 2006;312:623–629
   PubMed Web of Science ®Google Scholar
• Scott A, Fruttiger M. Oxygen-induced retinopathy: a model for vascular pathology in the retina. Eye 2010;24:416–421
   PubMed Web of Science ®Google Scholar
• Marcinkiewicz C. Applications of snake venom components to modulate integrin activities in cell-matrix interactions. Int J Biochem Cell Biol 2013;45:1974–1986
   PubMed Web of Science ®Google Scholar
• Hanson J, de Leval X, David JL, Supuran C, Pirotte B, Dogne JM. Progress in the field of GPIIb/IIIa antagonists. Curr Med Chem Cardiovasc Hematol Agents 2004;2:157–167
   PubMedGoogle Scholar
• Hammes HP, Brownlee M, Jonczyk A, Sutter A, Preissner KT. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat Med 1996;2:529–533
   PubMed Web of Science ®Google Scholar
• Manoukian SV. The relationship between bleeding and adverse outcomes in ACS and PCI: pharmacologic and nonpharmacologic modification of risk. J Iinvasive Cardiol 2010;22:132–141
   PubMed Web of Science ®Google Scholar
• Friess H, Langrehr JM, Oettle H, Raedle J, Niedergethmann M, Dittrich C, et al. A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer. BMC Cancer 2006;6:285
   PubMed Web of Science ®Google Scholar
• Hariharan S, Gustafson D, Holden S, McConkey D, Davis D, Morrow M, et al. Assessment of the biological and pharmacological effects of the alpha nu beta3 and alpha nu beta5 integrin receptor antagonist, cilengitide (EMD 121974), in patients with advanced solid tumors. Ann Oncol 2007;18:1400–1407
   PubMed Web of Science ®Google Scholar
• Davis GE, Senger DR. Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res 2005;97:1093–1107
   PubMed Web of Science ®Google Scholar
• Francis SE, Goh KL, Hodivala-Dilke K, Bader BL, Stark M, Davidson D, et al. Central roles of alpha5beta1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arterioscler Thromb Vasc Biol 2002;22:927–933
   PubMed Web of Science ®Google Scholar
• Peters JH, Hynes RO. Fibronectin isoform distribution in the mouse. I. The alternatively spliced EIIIB, EIIIA, and V segments show widespread codistribution in the developing mouse embryo. Cell Adhes Commun 1996;4:103–125
   PubMed Web of Science ®Google Scholar
• Peters JH, Chen GE, Hynes RO. Fibronectin isoform distribution in the mouse. II. Differential distribution of the alternatively spliced EIIIB, EIIIA, and V segments in the adult mouse. Cell Adhes Commun. 1996;4:127–148
   PubMed Web of Science ®Google Scholar
• George EL, Georges-Labouesse EN, Patel-King RS, Rayburn H, Hynes RO. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 1993;119:1079–1091
   PubMed Web of Science ®Google Scholar
• Georges-Labouesse EN, George EL, Rayburn H, Hynes RO. Mesodermal development in mouse embryos mutant for fibronectin. Dev Dyn 1996;207:145–156
   PubMed Web of Science ®Google Scholar
• Luo BH, Carman CV, Springer TA. Structural basis of integrin regulation and signaling. Annu Rev Immunol 2007;25:619–647
   PubMed Web of Science ®Google Scholar
• Garcia AJ, Takagi J, Boettiger D. Two-stage activation for alpha5beta1 integrin binding to surface-adsorbed fibronectin. Journal Biol Chem 1998;273:34710–34715
   PubMed Web of Science ®Google Scholar
• Garcia AJ, Schwarzbauer JE, Boettiger D. Distinct activation states of alpha5beta1 integrin show differential binding to RGD and synergy domains of fibronectin. Biochemistry 2002;41:9063–9069
   PubMed Web of Science ®Google Scholar
• Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242–248
   PubMed Web of Science ®Google Scholar
• Youn SW, Lee SW, Lee J, Jeong HK, Suh JW, Yoon CH, et al. COMP-Ang1 stimulates HIF-1alpha-mediated SDF-1 overexpression and recovers ischemic injury through BM-derived progenitor cell recruitment. Blood 2011;117:4376–4386
   PubMed Web of Science ®Google Scholar
• Kim MS, Lee CS, Hur J, Cho HJ, Jun SI, Kim TY, et al. Priming with angiopoietin-1 augments the vasculogenic potential of the peripheral blood stem cells mobilized with granulocyte colony-stimulating factor through a novel Tie2/Ets-1 pathway. Circulation 2009;120:2240–2250
   PubMed Web of Science ®Google Scholar
• Joo HJ, Kim H, Park SW, Cho HJ, Kim HS, Lim DS, et al. Angiopoietin-1 promotes endothelial differentiation from embryonic stem cells and induced pluripotent stem cells. Blood 2011;118:2094–2104
   PubMed Web of Science ®Google Scholar
• Cascone I, Napione L, Maniero F, Serini G, Bussolino F. Stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1. J Cell Biol 2005;170:993–1004
   PubMed Web of Science ®Google Scholar